Wilshire · Q1 2026 · Published 31 March 2026 · Essay or commentary
Wilshire Small Company Growth Portfolio Schedule of Investments, March 31, 2026
Wilshire reports that the Wilshire Small Company Growth Portfolio held 97.8% of its $21.5 million net assets in common stocks on March 31, 2026, with health care (24.3%) and industrials (23.4%) the largest sectors.
Summary
This is the unaudited schedule of investments of the Wilshire Small Company Growth Portfolio as of March 31, 2026, listing each holding by sector with shares and value. Common stocks made up 97.8% of the fund's $21.5 million net assets, spread over several hundred small positions. No position exceeded about $330,000, or 1.5% of net assets. The document carries no commentary; it is a holdings filing.
Key insights
- Health care was 24.3% of net assets, industrials 23.4%, information technology 17.4% and financials 10.2%.
- Sterling Infrastructure was the largest holding at $328,667, followed by Ligand Pharmaceuticals ($294,883) and Cogent Biosciences ($255,381).
- Federal Signal ($254,345), UL Solutions ($248,559) and Pegasystems ($247,401) completed the top six.
- Total investments were $21.2 million (98.5%), with $455,585 (2.1%) in the U.S. Bank money market deposit account, which paid 3.49% on March 31, 2026.
- Liabilities exceeded other assets by $138,376, or 0.6% of net assets.
Companies discussed
More